HG-10-102-01 - LRRK2 Inhibitor. CAS# 1351758-81-0 size:2mg solid (2017) Cancer Lett

(2017) Cancer Lett

Smiles: OC(=O)CCC1=C(NC2=CC(Cl)=CC(Cl)=C12)C(O)=O

MDL29951 promotes Ca2+ signaling responses and inhibition of cyclic adenosine monophosphate (cAMP) accumulation in rat oligodendrocyte precursor cells during the period of peak GPR17 abundance

21)27-14-6-4-13(5-7-14)25-16-9-15(23-10-24-16)11-2-1-3-12(8-11)17(22)26/h1-10H

Smiles: CC1=CC2C(=CC=CC=2C(N)=O)N1C1=NC2CCOCC=2C(NCC2C=CC=CC=2)=N1

HG-10-102-01 - LRRK2 Inhibitor. CAS# 1351758-81-0 size:2mg solid (2017) Cancer LettHG 10 102 01, CAS No. 1351758 81 0, is a brain penetrant, potent and selective inhibitor of wild type LRRK2 and the G2019S mutant (IC50 for LRRK2 wild type ~20. 3 nM and LRRK2 [G2019S] ~3. 2 nM). It significantly inhibits Ser910 and Ser935 phosphorylation of both wild type LRRK2 and G2019S mutant at a concentration of 0. 10. 3 M in cells. HG 10 102 01 is the first compound reported to be capable of inhibiting Ser910 and Ser935 phosphorylation in mouse